Evidence map›Paper›PMID 40629197›Full record

ArticleEJNMMI radiopharmacy and chemistry2025

Rapid cleavage of 6-[

Pyry Dillemuth, Abiodun Ayo, Xiaoqing Zhuang, Petter Lövdahl, Heidi Liljenbäck, Salli Kärnä, Tatsiana Auchynnikava, Jonne Kunnas, Jesse Ponkamo, Maxwell W G Miner and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI radiopharmacy and chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. [ACS omega · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Pyry DillemuthTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, Turku, FI-20520, Finland.
Abiodun AyoTranslational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Xiaoqing ZhuangTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, Turku, FI-20520, Finland.
Petter LövdahlTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, Turku, FI-20520, Finland.
Heidi LiljenbäckTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, Turku, FI-20520, Finland.
Salli KärnäTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, Turku, FI-20520, Finland.
Tatsiana AuchynnikavaTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, Turku, FI-20520, Finland.
Jonne KunnasTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, Turku, FI-20520, Finland.
Jesse PonkamoTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, Turku, FI-20520, Finland.
Maxwell W G MinerTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, Turku, FI-20520, Finland.
Johan RajanderTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, Turku, FI-20520, Finland.
Jessica M RosenholmPharmaceutical Sciences Laboratory, Faculty of Science and Engineering, Åbo Akademi University, Turku, Finland.
Anne RoivainenTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, Turku, FI-20520, Finland.
Anu J AiraksinenTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, Turku, FI-20520, Finland.
Pirjo LaakkonenTranslational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Xiang-Guo LiTurku PET Centre, University of Turku, Kiinamyllynkatu 4-8, Turku, FI-20520, Finland. xiali@utu.fi.ORCID http://orcid.org/0000-0002-9118-7223

Funding

Syöpäsäätiö 2024
6 · The paper itself

Abstract

backgroundPeptides radiolabeled with fluorine-18 are frequently synthesized using prosthetic groups. Among them, activated esters of 6-[

results[

conclusionsBoth [

Indexed as

6-[18F]fluoronicotinic acidFluorine-18Peptide radiolabelingPETProsthetic group

Identifiers

PMID40629197
PMCPMC12238435

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.